Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators.


Journal

European urology oncology
ISSN: 2588-9311
Titre abrégé: Eur Urol Oncol
Pays: Netherlands
ID NLM: 101724904

Informations de publication

Date de publication:
10 2020
Historique:
received: 08 05 2019
revised: 19 08 2019
accepted: 30 08 2019
pubmed: 25 9 2019
medline: 1 6 2021
entrez: 25 9 2019
Statut: ppublish

Résumé

The 2019 European Association of Urology guidelines recommend multiparametric magnetic resonance imaging (mpMRI) for biopsy-naïve patients with clinical suspicion of prostate cancer (PC) and avoiding biopsy in patients with negative mpMRI and low clinical suspicion. However, consensus on the optimal definition of low clinical suspicion is lacking. We evaluated 266 biopsy-naïve patients who underwent mpMRI, the 4Kscore test, and prostate biopsy to define the best strategy to avoid unnecessary testing and biopsies. The European Randomized Study of Screening for Prostate Cancer risk calculator (ERSPC-RC) and prostate-specific antigen density (PSAd) were also considered. For men with Prostate Imaging-Reporting and Data System v2.0 (PI-RADS) 1⿿2 lesions, the highest negative predictive value was observed for those with low or intermediate 4Kscore risk (96.9% and 97.1%), PSAd <0.10ng/ml/cm

Identifiants

pubmed: 31548130
pii: S2588-9311(19)30141-5
doi: 10.1016/j.euo.2019.08.015
pii:
doi:

Substances chimiques

Prostate-Specific Antigen EC 3.4.21.77

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

700-704

Informations de copyright

Copyright © 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Ugo Giovanni Falagario (UG)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Urology and Organ Transplantation, University of Foggia, Foggia, Italy. Electronic address: ugofalagario@gmail.com.

Alberto Martini (A)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Ethan Wajswol (E)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Patrick-Julien Treacy (PJ)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Parita Ratnani (P)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Ivan Jambor (I)

Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Radiology, University of Turku, Turku, Finland.

Harry Anastos (H)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Sara Lewis (S)

Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Kenneth Haines (K)

Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Luigi Cormio (L)

Department of Urology and Organ Transplantation, University of Foggia, Foggia, Italy.

Giuseppe Carrieri (G)

Department of Urology and Organ Transplantation, University of Foggia, Foggia, Italy.

Ardeshir R Rastinehad (AR)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Peter Wiklund (P)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Ash Tewari (A)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH